The Role of Ad-36 and Its E4orf-1 Protein in Modulating Glycemic Control
Current treatment strategies for Type 2 Diabetes Mellitus (T2DM) include a range of anti-diabetic drugs, supplemented by lifestyle modifications to reduce dietary fat intake and body fat. However, for their anti-diabetic action, most drugs recruit insulin signaling pathways, which are already impair...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
LSU
2011
|
| Subjects: | |
| Online Access: | http://etd.lsu.edu/docs/available/etd-06082011-093407/ |